Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia - Wikidata - wikimedia - TriplyDB

Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia

Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia

http://www.wikidata.org/entity/Q27477833

about

Analysis of peripheral blood dendritic cells as a non-invasive tool in the follow-up of patients with chronic hepatitis C Managing Occupational Risks for Hepatitis C Transmission in the Health Care Setting Occult persistence and lymphotropism of hepatitis C virus infection Elevation of interleukin-18 in chronic hepatitis C: implications for hepatitis C virus pathogenesis Determinants of viral clearance and persistence during acute hepatitis C virus infection The ribavirin analog ICN 17261 demonstrates reduced toxicity and antiviral effects with retention of both immunomodulatory activity and reduction of hepatitis-induced serum alanine aminotransferase levels Promising candidates for the treatment of chronic hepatitis C.Relationships between cellular immune responses and treatment outcomes with interferon and ribavirin in HIV/hepatitis C virus co-infection.The wild-type hepatitis C virus core inhibits initiation of antigen-specific T- and B-cell immune responses in BALB/c mice Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C.DNA vaccination: a potential weapon against infection and cancer.Mechanisms of action of ribavirin in antiviral therapies.Spontaneous elimination of hepatitis C virus infection: a retrospective study on demographic, clinical, and serological correlates Combined effect of pro- and anti-inflammatory cytokine gene polymorphisms on susceptibility to liver cirrhosis in Tunisian HCV-infected patients.Persistence of Hepatitis C Virus Traces after Spontaneous Resolution of Hepatitis C DNA vaccination protects mice against challenge with Listeria monocytogenes expressing the hepatitis C virus NS3 protein.The Role of Interferon Gamma Gene Polymorphism (+874A/T, +2109A/G, and -183G/T) in Response to Treatment Among Hepatitis C Infected Patients in Fars Province, Southern Iran.Reduction of retrovirus-induced immunosuppression by in vivo modulation of T cells during acute infection.Virus-Specific Cellular Response in Hepatitis C Virus Infection.Exploration of potential mechanisms of hepatitis C virus resistance in exposed uninfected intravenous drug users.Anti-envelope antibody responses in individuals at high risk of hepatitis C virus who resist infection Quantitative and functional differences in CD8+ lymphocyte responses in resolved acute and chronic hepatitis C virus infection.Haplotype analysis finds linkage disequilibrium in the IL-12 gene in patients with HCV.The Impact of IFN-γ Gene Polymorphisms on Spontaneous Clearance of HCV Infection in Fars Province, Southern of Iran.CD81 sequence and susceptibility to hepatitis C infection.Patients with chronic hepatitis C express a high percentage of CD4(+)CXCR5(+) T follicular helper cells.Effects of the CCR5-Delta32 mutation on hepatitis C virus-specific immune responses in patients with haemophilia.Effect of cytokine gene polymorphism on histological activity index, viral load and response to treatment in patients with chronic hepatitis C genotype 3.Effects of the CCR5-Delta32 mutation on hepatitis C virus-specific immune responses in patients with haemophilia.Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages.Hepatitis C virus infection in renal failure patients in the absence of anti-hepatitis C virus antibodies.Elevated frequency and function of regulatory T cells in patients with active chronic hepatitis C.Cytokine profiles in high risk injection drug users suggests innate as opposed to adaptive immunity in apparent resistance to hepatitis C virus infection.Interleukin 12B gene polymorphism and apparent resistance to hepatitis C virus infection.Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia.Immunopathogenesis of hepatitis C virus infection

P2860

Q26773283-C0C30A66-725E-4C48-A2FF-49FE9B2FA7D7 Q27477626-84E2A307-4C2F-408C-AAE1-14C49DE67527 Q27488897-BD38C518-6669-4A20-AD22-F4F40C6C1723 Q27489815-D3AE4E3B-CE23-472E-9950-5453E1052099 Q28131757-331A2D84-84AC-4F7E-B90B-2A3598A626B6 Q28344154-BBFD191C-7BD8-4220-8C71-F4BB65BC0DDB Q30333233-F0F490C6-8CF3-42FB-831C-9E87A7C13CE7 Q33767267-46AA0D54-9327-4BE2-BE4D-2E8AD9E0118F Q33962697-73DCC84D-3385-48AD-8D30-7E73876CA43C Q34152354-9A50B7F4-46DA-4965-80E0-79AD6F7C10FC Q34242413-D34CE93F-D742-416A-8C6F-75BECA6F5E2B Q34521747-DF98BE1F-2F54-41F0-B038-E9D828A6E231 Q34604833-4DF7942D-F36C-4A25-B9BC-BFB3B4649156 Q34959537-BEFD5D1A-1FB6-41B7-B25C-5EF25C67BFF2 Q35810396-B4B4EEFB-954C-46C3-AECF-01E4975C2E4E Q36376020-E3EEBADE-C4AD-49A8-BF1F-78D979A55CF5 Q37540477-76EE8F02-DC47-4F24-995C-0444384EB885 Q37583435-5E922912-994C-4411-AA33-80B5537AD162 Q38597605-8777084C-DACB-4035-9162-AA713A8A0306 Q39285745-77AECA54-E15D-4229-87EA-082282015C01 Q40471338-48D4B17F-BF0A-450A-809B-F93AD5AB5854 Q40750023-772CF34E-A75D-436D-BD17-E0872FB16FC4 Q41020331-3F6F0C55-F8C3-46C3-80EB-259EB4DFFD06 Q41216716-4260BE1C-58CA-4DE3-8B7E-BFD4A05E93E8 Q42262704-16DC62C0-B68E-4918-83C9-CD1964D835A8 Q42978466-49C7AA37-4522-474A-8C67-4444FFC50DCD Q42984759-EC28F10A-E35B-42A1-AF79-8AA11E0C167A Q42997726-E7914C2D-251B-44F6-ABE0-AB551FEAB57F Q43023517-5EDFCA74-797E-4568-93B7-DEF84FE0B429 Q43036009-4B4720DC-8CB5-4C82-BAED-B5F72B0503B1 Q43036910-2FE1AE5E-B72E-4358-A430-111DBD8893B5 Q44433005-084559B2-4416-4163-A435-B9F54675EC53 Q44873304-5A713D94-9019-40E5-9277-58612F1B26ED Q45395726-F0B0510A-BA20-40F4-BA70-4DF6A9EBDDD3 Q45735396-E2E200A3-CCFD-4065-BB8F-5B9D58D9B992 Q59200582-B0F60693-7DF8-4389-9132-E979763BD15A

P2860

Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia

http://www.wikidata.org/entity/Q27477833

description

1999 nî lūn-bûn

@nan

1999 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի մարտին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Hepatitis C virus (HCV) specif ...... s without hepatitis C viraemia

@ast

Hepatitis C virus (HCV) specif ...... s without hepatitis C viraemia

@en

Hepatitis C virus (HCV) specif ...... s without hepatitis C viraemia

@nl

type

label

Hepatitis C virus (HCV) specif ...... s without hepatitis C viraemia

@ast

Hepatitis C virus (HCV) specif ...... s without hepatitis C viraemia

@en

Hepatitis C virus (HCV) specif ...... s without hepatitis C viraemia

@nl

prefLabel

Hepatitis C virus (HCV) specif ...... s without hepatitis C viraemia

@ast

Hepatitis C virus (HCV) specif ...... s without hepatitis C viraemia

@en

Hepatitis C virus (HCV) specif ...... s without hepatitis C viraemia

@nl

P1433

Q27477833-EECCABC4-41AF-42FE-976C-48AA9DC9C06D

P1476

Q27477833-B6F4BDB6-6C70-41E5-8834-28CCE3035C67

P2093

Q27477833-1AEE2557-F0D9-4157-BAF9-C4182BEBDDB6

Q27477833-5E8214DB-DBA9-45EB-B3E6-A9BA0745E203

Q27477833-61868DAA-25F0-4040-BFCB-6B19F204B913

Q27477833-7432C99F-15B2-4540-93A9-802EDD1BF206

Q27477833-7BD7D593-2D2D-4A2B-BC19-5EEC8D1D4411

Q27477833-BCA3F1A7-3AD2-4829-8483-066BA97456BA

Q27477833-F26E0477-CC45-408A-AC5A-C849B4D98812

P2860

Q27477833-0EB9743F-F261-4D6F-9579-C3EC52989F53

Q27477833-0F5DBB1A-F412-4F9B-8013-997A1649FA69

Q27477833-183ED498-D831-42B0-8A2C-27905D7448E4

Q27477833-1D1ACCEC-31A8-4C85-8F1A-E4C5ED3BB50C

Q27477833-357B8FEF-A65A-433D-9B71-554048E6111D

Q27477833-3D4C3893-EC4C-4261-812E-676C01B6DFF9

Q27477833-3FD4D6C5-C326-4C8C-A5D8-926428AD0FE3

Q27477833-580F6D01-09F7-4001-BAC1-D808F20DDDD9

Q27477833-627EE06E-5DA8-4AB4-BC0A-C379A9ECFFC1

Q27477833-66305C90-5102-4FC4-BF37-11DD90F30A5E

P304

Q27477833-9A890B0F-03C4-4E80-85D2-BBE1DAD612DD

P31

Q27477833-C4CE9473-621D-41FD-A39B-33C8D396B2CD

P3181

Q27477833-12339E86-2030-4BD7-8C9E-4CBB7619C61A

P356

Q27477833-03A92D50-161E-4581-A609-AD8046F3017D

P407

Q27477833-6A706C7A-689E-4AB6-A9DC-B97E7A27FF27

P433

Q27477833-9543AAE3-5154-4168-90AE-5D8C61B4B970

P478

Q27477833-393B8356-D1F4-4B07-9D6B-D67C4FADAA34

P577

Q27477833-54CE54EE-3469-4197-934C-96B6C5573D64

P5875

Q27477833-C395AE42-7667-4EB7-ACC7-FB51BE197CAA

P698

Q27477833-7B3A179A-AF82-47B6-9D96-7608CC008200

P921

Q27477833-FEDB4271-FC8F-46E6-8736-C9F68F07DE6B

P932

Q27477833-E6BB96DB-53D2-4A73-9004-86D971DE6585

P3181

P356

P1433

P1476

Hepatitis C virus (HCV) specif ...... s without hepatitis C viraemia

@en

P2093

G Maertens

http://www.w3.org/2001/XMLSchema#string

M E Cramp

http://www.w3.org/2001/XMLSchema#string

N V Naoumov

http://www.w3.org/2001/XMLSchema#string

P Carucci

http://www.w3.org/2001/XMLSchema#string

R Williams

http://www.w3.org/2001/XMLSchema#string

S Chokshi

http://www.w3.org/2001/XMLSchema#string

S Rossol

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical significance of intrahepatic hepatitis C virus levels in patients with chronic HCV infection

Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules

Compartmentalization of T lymphocytes to the site of disease: intrahepatic CD4+ T cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C

Structural proteins of hog cholera virus expressed by vaccinia virus: further characterization and induction of protective immunity

Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1

Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins

Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis

Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

P304

424-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4571928

http://www.w3.org/2001/XMLSchema#string

P356

10.1136/GUT.44.3.424

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P577

1999-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13263896

http://www.w3.org/2001/XMLSchema#string

P698

10026332

http://www.w3.org/2001/XMLSchema#string

P921

P932

1727419

http://www.w3.org/2001/XMLSchema#string